Bausch Health Companies Inc (BHC)
Bausch Health Notification
Exicure Inc. (XCUR)
Exicure, Inc. - Exicure to Present Data from Burixafor Phase 2 Trial at the 2026 Tandem Meetings
Quidel Corporation (QDEL)
QuidelOrtho Corporation - QuidelOrtho to Report Fourth Quarter and Full-Year 2025 Financial Results
Exicure Inc. (XCUR)
Exicure to Present Data from Burixafor Phase 2 Trial at the 2026 Tandem Meetings
Ocular Therapeutix Inc (OCUL)
Ocular Therapeutix™ Appoints David W. Robinson as Global Chief Commercial Officer
Lisata Therapeutics Inc (LSTA)
Lisata Therapeutics Enters Into Term Sheet to be Acquired by Kuva Labs for $4.00 Per Share in an All-Cash Tender Offer
Bausch Health Companies Inc (BHC)
Bausch Health to Announce Fourth Quarter and Full Year 2025 Results on February 18, 2026
Quidel Corporation (QDEL)
QuidelOrtho to Report Fourth Quarter and Full-Year 2025 Financial Results
Johnson & Johnson (JNJ)
Johnson & Johnson - Johnson & Johnson reports Q4 and Full-Year 2025 results
Johnson & Johnson (JNJ)
Johnson & Johnson reports Q4 and Full-Year 2025 results
Portage Biotech Inc. (PRTG)
Daxor Corporation (DXR)
Avalo Therapeutics Inc. (AVTX)
Natera Inc (NTRA)
Natera - Natera Publishes Clinical Validation ofLatitude™ Tissue-Free MRD Test in Colorectal Cancer